Trials / Completed
CompletedNCT03562650
Text Message Treatment for Social Anxiety
Computerized Treatment for Social Anxiety
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Florida State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.
Detailed description
This study hopes to assess whether a month long text message based safety behavior fading protocol is effective in reducing safety behaviors and social anxiety symptoms. Over the course of four consecutive weeks, text messages will be sent to participants the first day of the study and every other day for four weeks (14 texts in total). These text messages will remind participants to either avoid using their three most engaged in safety behaviors (assessed at pre-treatment) or to stay present-focused. The past week frequency of the participants' safety behaviors will be assessed at the beginning of pre-treatment, post-treatment, and four week follow up assessments Participants will be asked to complete an additional online questionnaire for both a post-treatment and a 4-week post-treatment follow up assessment. We hypothesize that: 1) the safety behavior group will show a greater overall reduction in social anxiety symptoms, 2) that the safety behavior group will show a reduction in the frequency of safety behavior use, and 3) that the present-focused group will show an increase in mindfulness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Safety Behavior Fading | Participants are asked to fade their three most common safety behaviors associated with their social anxiety |
| BEHAVIORAL | Present Centered | Participants are asked to try to increase their focus on the present. |
Timeline
- Start date
- 2018-01-27
- Primary completion
- 2019-03-27
- Completion
- 2019-03-27
- First posted
- 2018-06-19
- Last updated
- 2021-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03562650. Inclusion in this directory is not an endorsement.